^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | B Acute Lymphoblastic Leukemia |
| Drug: | Darzalex (daratumumab) (CD38 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
04/04/2022
Excerpt:
REGIMENS FOR RELAPSED OR REFRACTORY Ph-NEGATIVE T-ALL...Other Recommended Regimens...Daratumumab
